ATP-Bio Director John Bischof and ATP-Bio Industrial Advisory Board member Sebastian Giwa will talk 3:35-4:40 on Monday, February 13 on tissue and organ supply chains and recent advances from ATP-Bio research. More information about the presentations here
The promise of organ and tissue preservation to transform medicine
February 13
3:35 - 4:30pm CT
Control of Biological Time in Practice: Supply chain needs for tissues and organs in medicine and near-term technology applications
Sebastian Giwa, founder of Sylvatica Biotech, Expanse Bio, Ossium Health, Elevian Inc., and the Organ Preservation Alliance; IEM Fellow and Chairman of ATP-Bio Partners
Advanced technologies for the preservation of biological systems (ATP-Bio) NSF ERC
John Bischof, Professor of Mechanical and Biomedical Engineering; ATP-Bio and IEM Director
Sebastian Eriksson Giwa, Ph.D.
Co-founder of Elevian, Ossium Health, Sylvatica Biotech, and the Organ Preservation Alliance (incubated at SU Labs at NASA Research Park)
Nevada Donor Network
John Bischof, Ph.D.
Director, Institute for Engineering in Medicine
Director, ATP-Bio NSF ERC, Director, Office of Discovery and Translation (CTSI), Director, Office of Academic Clinical Affairs (CTSI)
Distinguished McKnight University Professor, Carl and Janet Kuhrmeyer Chair, Mechanical Engineering. Medtronic-Bakken Endowed Chair for Engineering in Medicine, University of Minnesota